Evidence map›Paper›PMID 34234147›Full record

Observational studyNature communications2021

GIGYF1 loss of function is associated with clonal mosaicism and adverse metabolic health.

Yajie Zhao, Stasa Stankovic, Mine Koprulu, Eleanor Wheeler, Felix R Day, Hana Lango Allen, Nicola D Kerrison, Maik Pietzner, Po-Ru Loh, Nicholas J Wareham and 3 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Genetic mechanisms of mitotic error in 840,853 blood genomes.medRxiv : the preprint server for health sciences · 2026
    Article
  3. Article
  4. Proteogenomic Analysis of Coronary Artery Calcification in Human Populations.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Yajie ZhaoMRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.ORCID 0000-0002-2747-0219
Stasa StankovicMRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.ORCID 0000-0002-6602-1379
Mine KopruluMRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
Eleanor WheelerMRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.ORCID 0000-0002-8616-6444
Felix R DayMRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.ORCID 0000-0003-3789-7651
Hana Lango AllenMRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
Nicola D KerrisonMRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
Maik PietznerMRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.ORCID 0000-0003-3437-9963
Po-Ru LohDivision of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-5542-9064
Nicholas J WarehamMRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.ORCID 0000-0003-1422-2993
Claudia LangenbergMRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.ORCID 0000-0002-5017-7344
Ken K OngMRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.ORCID 0000-0003-4689-7530
John R B PerryMRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK. john.perry@mrc-epid.cam.ac.uk.ORCID 0000-0001-6483-3771
University of Cambridge · GBBroad Institute · US

Funding

Revealing somatic genome alterations and their clinical sequelae: Ultrasensitive computational detection of mosaic structural variantsDP2ES030554 · NIEHS · BRIGHAM AND WOMEN'S HOSPITAL · PI LOH, PO-RU · 2018 to 2018
$2.7M
Department of HealthMedical Research Council MC_PC_17228Medical Research Council MC_QA137853Medical Research Council MC_UU_00006/1Medical Research Council MC_UU_00006/2Medical Research Council MC_UU_12015/1Medical Research Council MC_UU_12015/2NIEHS NIH HHS DP2 ES030554
6 · The paper itself

Abstract

Mosaic loss of chromosome Y (LOY) in leukocytes is the most common form of clonal mosaicism, caused by dysregulation in cell-cycle and DNA damage response pathways. Previous genetic studies have focussed on identifying common variants associated with LOY, which we now extend to rarer, protein-coding variation using exome sequences from 82,277 male UK Biobank participants. We find that loss of function of two genes-CHEK2 and GIGYF1-reach exome-wide significance. Rare alleles in GIGYF1 have not previously been implicated in any complex trait, but here loss-of-function carriers exhibit six-fold higher susceptibility to LOY (OR = 5.99 [3.04-11.81], p = 1.3 × 10

Indexed as

Genetic Predisposition to DiseaseMosaicismAdultAgedCarrier ProteinsCase-Control StudiesChromosomes, Human, YDiabetes Mellitus, Type 2DNA Mutational AnalysisExome SequencingFemaleGenome-Wide Association StudyHumansInsulinLeukocytesLoss of Function MutationCarrier ProteinsGIGYF1 protein, humanIGF1R protein, humanInsulinReceptor, IGF Type 1

Identifiers

PMID34234147
PMCPMC8263756
OpenAlexW3179300690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.